You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 11, 2025

Drug Price Trends for NDC 25021-0815


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 25021-0815

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
LEUCOVORIN CALCIUM 200MG/VIL (PF) INJ Sagent Pharmaceuticals 25021-0815-30 1 5.98 5.98000 2024-05-01 - 2029-04-30 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for Leucovorin Calcium (NDC: 25021-815-30)

Last updated: January 19, 2025

Introduction

Leucovorin Calcium, with the NDC code 25021-815-30, is a chemically reduced derivative of folic acid, used as an antidote to drugs that act as folic acid antagonists. Here, we will delve into the market analysis and price projections for this drug.

Market Context

The pharmaceutical market is undergoing significant changes driven by various trends, including a shift towards prevention, personalization, and prediction of health outcomes[3].

Product Overview

Leucovorin Calcium is marketed by Sagent Pharmaceuticals and is categorized as a human prescription drug. It is available in the form of an injection, powder, lyophilized, for solution[1].

Pricing Dynamics

Pricing in the pharmaceutical industry is influenced by several factors, including manufacturing costs, marketing costs, distribution costs, and the need to provide rebates and discounts.

Current Pricing

The pricing for Leucovorin Calcium can vary based on the dosage and packaging. However, specific pricing details for this NDC code are not provided in the available sources. Generally, the Wholesale Acquisition Cost (WAC) pricing for similar drugs can give some insight into the pricing structure.

For example, the WAC pricing for other drugs can include significant reductions when generic versions are introduced. Dr. Reddy's Laboratories introduced Lenalidomide with a 14% reduction in WAC pricing compared to the branded version, Revlimid[2].

Price Projections

Given the lack of specific pricing data for Leucovorin Calcium, we can infer from broader industry trends:

  • Generic Competition: If generic versions of Leucovorin Calcium are introduced, it is likely that the prices will decrease. Patent expirations and the entry of generic drugs can significantly reduce the market price of a drug, as seen with Tarceva and Alimta in the NSCLC market[4].

  • Market Demand: The demand for Leucovorin Calcium is influenced by its use as an antidote to folic acid antagonists. If the use of these antagonists increases, the demand for Leucovorin Calcium could rise, potentially stabilizing or increasing its price.

  • Regulatory and Policy Changes: Changes in healthcare policies and regulatory environments can impact pricing. For instance, new policies might affect the pricing strategies of pharmaceutical companies, including those producing Leucovorin Calcium[3].

Market Drivers and Barriers

Drivers

  • Increasing Use in Combination Therapies: Leucovorin Calcium is often used in combination with other drugs to enhance their efficacy or mitigate side effects. An increase in the use of these combination therapies could drive up demand and potentially stabilize or increase prices.
  • Advancements in Treatment Protocols: As treatment protocols evolve, the role of Leucovorin Calcium might become more critical, leading to increased demand and potentially higher prices.

Barriers

  • Generic Competition: The introduction of generic versions of Leucovorin Calcium would likely reduce its market price significantly.
  • Regulatory Pressures: Increased regulatory scrutiny and policies aimed at reducing healthcare costs could pressure pharmaceutical companies to lower prices.

Global Pharmaceutical Market Trends

The pharmaceutical industry is experiencing several transformative trends that could impact the pricing and market dynamics of drugs like Leucovorin Calcium:

  • Personalization and Prevention: There is a growing focus on personalized and preventive healthcare, which might influence the use and pricing of supportive drugs like Leucovorin Calcium[3].

  • Immunotherapies and Targeted Therapies: The rise of immunotherapies and targeted therapies in various cancer treatments, such as NSCLC, indicates a shift towards more expensive but effective treatments. This could indirectly affect the pricing of supportive drugs by influencing overall treatment costs[4].

Key Takeaways

  • Pricing Sensitivity: The price of Leucovorin Calcium is sensitive to generic competition, regulatory changes, and market demand.
  • Market Trends: The pharmaceutical industry's shift towards personalization, prevention, and advanced therapies could influence the role and pricing of supportive drugs.
  • Regulatory Impact: Changes in healthcare policies and regulatory environments will continue to shape the pricing strategies of pharmaceutical companies.

FAQs

  1. What is Leucovorin Calcium used for?

    • Leucovorin Calcium is used as an antidote to drugs that act as folic acid antagonists.
  2. How does generic competition affect drug prices?

    • Generic competition typically leads to a significant reduction in drug prices, as seen with the introduction of generic versions of Tarceva and Alimta[4].
  3. What are the key trends shaping the pharmaceutical industry?

    • Key trends include a focus on prevention, personalization, prediction, and point of care, along with regulatory and policy changes[3].
  4. How do regulatory changes impact drug pricing?

    • Regulatory changes can pressure pharmaceutical companies to lower prices and can influence the overall pricing strategy of the industry.
  5. What is the impact of immunotherapies on the pharmaceutical market?

    • Immunotherapies are driving significant growth in the pharmaceutical market, particularly in cancer treatments like NSCLC, and can indirectly affect the pricing of supportive drugs[4].

Sources

  1. DailyMed - LEUCOVORIN CALCIUM injection, powder, lyophilized, for solution
  2. Minnesota Department of Health - New Prescription Drug Price Reporting
  3. PwC - Pharma industry trends: PwC
  4. GlobalData - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025
  5. FDA - NDC Directory (March 2015)

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.